about
progesterone metabolic processferulate metabolic processL-phenylalanine metabolic processtetrahydrobiopterin metabolic processcobalamin metabolic processdopamine metabolic processglycolate metabolic processdrug catabolic processantibiotic metabolic processadenosine metabolic processfolic acid metabolic processATP biosynthetic processS-adenosylmethionine metabolic processcalcitriol biosynthetic process from calciolsuccinate metabolic processnitric oxide metabolic processallantoin metabolic processcreatine metabolic processriboflavin metabolic processuracil metabolic processalpha-linolenic acid metabolic processcocaine metabolic processglycine metabolic processD-serine metabolic processthiamine-containing compound metabolic processplatelet activating factor metabolic processquinolinate metabolic processphytol metabolic processchitin metabolic processAMP metabolic processL-proline biosynthetic processfluorene metabolic processtrichloroethylene metabolic processnaphthalene metabolic processhydrogen sulfide metabolic processbiotin metabolic processoxygen metabolic processvitamin B6 metabolic processnicotinamide metabolic processdermatan sulfate metabolic process
P279
Cytochrome P450 family 1 subfamily A member 1Cytochrome P450, family 2, subfamily e, polypeptide 1Thiopurine methyltransferaseCytochrome P450, family 1, subfamily a, polypeptide 2Deoxycytidine kinaseFlavin containing monooxygenase 3Cytochrome P450, family 1, subfamily a, polypeptide 1Flavin containing dimethylaniline monoxygenase 1Flavin containing dimethylaniline monoxygenase 25'-nucleotidase, cytosolic IICytochrome P450 family 4 subfamily F member 12Adenosine deaminase likeEpoxide hydrolase 2Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotaseUDP glucuronosyltransferase family 1 member A6UDP glucuronosyltransferase family 1 member A4UDP glucuronosyltransferase family 1 member A3UDP glucuronosyltransferase family 1 member A7UDP glucuronosyltransferase family 1 member A10Carbonyl reductase 1Cytochrome P450 family 4 subfamily F member 2UDP glucuronosyltransferase family 1 member A9UDP glucuronosyltransferase family 1 member A8Alcohol dehydrogenase 1A (class I), alpha polypeptideVitamin K epoxide reductase complex subunit 1Aldehyde oxidase 3Aldehyde oxidase 1Aldehyde oxidase 4Aldehyde oxidase 2Cytochrome P450 2B10Flavin containing monooxygenase 1Cytochrome P450, family 4, subfamily f, polypeptide 18Carbonyl reductase 1Vitamin K epoxide reductase complex, subunit 1Flavin containing monooxygenase 2Sulfotransferase 1A1Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotaseAldehyde oxidase 1Pyrazinamidase/nicotinamidase PncA Rv2043cFlavin containing dimethylaniline monoxygenase 1
P682
Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed proteinInfluence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patientsGenetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarctionPrediction of cytochrome P450 isoform responsible for metabolizing a drug moleculeHydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearanceIn vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.Aldehyde oxidase 1 (AOX1) in human liver cytosols: quantitative characterization of AOX1 expression level and activity relationship.Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.Baeyer-Villiger Monooxygenase FMO5 as Entry Point in Drug Metabolism.A Baeyer-Villiger oxidation specifically catalyzed by human flavin-containing monooxygenase 5
P921
Q14358865-7568CCEF-94C9-43F8-912E-639B8728602FQ14819875-8636B7F2-3BF1-45DB-BDDA-551E39A75364Q14851788-D61CB602-3FFC-41E9-81F6-18BE3EC45B7FQ14851797-2B55CC20-6585-4788-A89E-D001E21A4D83Q14859652-1971D366-2E0E-4053-AF9C-9370121419C0Q14862273-B5FA5586-0B0D-40E0-A2BD-4BD8BAF5B35BQ14863686-1D1BF8C6-E656-4680-8AF0-7EC9C5393637Q14864415-067B73EE-CFAD-4D54-8AB9-410A6B15CE08Q14864619-F492DC43-2479-4648-ACA6-62701C880566Q14864792-A662B36D-EF1F-486E-9F86-45CF8DFAE09DQ14864920-9FE5EE12-D4F6-4C66-B3F7-F5FCE31921B1Q14865087-1265C398-53C6-453F-B931-DD2FAE3C4AF0Q14905781-2FBD49EC-8020-4406-8465-545A77766374Q14905955-924C904D-23AB-4D7A-89FF-07830BCAC86FQ14907255-CB536CDB-FE5C-47C3-804B-48D0E17D3F62Q14907441-E0AB23D3-4214-4A7C-88BF-A5F3282165D4Q14907616-559F2A31-5647-4560-A469-AE512FBFE72EQ14907623-C74A0591-D7F8-4E02-B064-D85E13437AD0Q14907829-FFDCCCB2-9574-4CAA-B704-FBEA0DDB6508Q14911887-1451B739-04C6-4AD4-BC60-E01F292857D1Q14912805-1543F8F0-D285-4502-A335-E67891B7CDF4Q14913509-46EC9F42-5F01-40D7-9CCC-5BBF30309979Q14914197-E198490A-4A62-4789-AEE2-90C98AC5E51BQ14914215-D85EFE55-B22C-455D-A2A6-793552D70C8DQ14914293-90B12D77-5162-4D17-B4C6-7410EED36FD7Q15319430-E9974CE4-C0F1-4255-986C-AFB48336AFEDQ21096264-F5CB9FE4-A599-4525-BF0E-61786C4ADC00Q21097155-C696C176-C642-4C3C-8173-2145646D1614Q21100757-E55A72FF-4CB8-4672-802C-D33D4B391306Q21103432-EAC3B6B9-4620-4401-AC4A-DFE0A101633CQ21105320-AC11A42A-4838-4B4B-BE9F-C2A288664DDAQ21109896-3AB0C7F6-8EE7-42EF-9B4E-C01AE2A5177BQ21110744-4F0347DD-2885-41EF-8656-9889763AAEC1Q21110745-040DC545-A646-41DD-BCF9-F8D8E9B7C319Q21112368-6FF14DEB-DCDF-47ED-B3ED-DAD0B5D6905CQ21113699-C36C5B03-3A4D-48CB-A82F-1710D6BB18A2Q21119973-9F72EBDD-4469-4007-943B-C6CC32D2C9B8Q21123305-D222DA3B-3912-4694-83A7-8255C4F0C8A5Q21123341-EF7E8AF3-BD98-48C6-8E89-2F3F3C3C5747Q21422558-BC139B4D-2819-4DAE-B9DA-417747799FB8
P279
Q1407929-84296BA0-CE20-4B5B-BB2E-342D4AD16012Q14864436-D47ECC1A-353D-4C97-9C85-4C1E4E6160F2Q14880764-4E96F52F-3BAB-4ED5-BD6A-3FB7D2E8FDDEQ14890105-F4BFC8A5-ED0A-47BD-B021-591C352376C8Q14914179-66BF68D1-0108-4F26-8766-D56B325E8748Q14914446-D1FF7241-5D94-49A9-ACD5-E1E6CD762E39Q14916463-24127094-7809-41F4-8FEA-903D6BB5E40DQ21101459-2DCCAF88-2354-48F8-B122-6501C9EC5BCCQ21101467-127106FC-0BD9-432E-AF3C-640AD33B0D2BQ21109362-9FA02073-2A9F-49FD-A49C-1DDB609F4B48Q21109918-BA276FCC-8776-4A1A-B7B3-DB33ACFCBF14Q21113745-DAB2D9D2-EE27-4D88-8DB6-8090B842C4A7Q21118391-72E3A123-6283-4572-86FE-DE7FFD461C37Q21121202-6927C617-92AF-4FBE-9A0A-F1E76BE1695CQ21121202-C0850EAB-C3B9-4D84-A466-A6D45D26BD07Q21123549-D50D006E-C05A-497F-B3EB-8F103032AA57Q21123552-6CA06F27-2EC1-481B-8C5B-CE915E76D0BBQ21123553-9DE4DB0A-A225-4AF0-B2C7-839CECB0D2C4Q21123567-0F26CD86-5AB9-4BF3-AE3D-419565377FD0Q21123567-9871C8C3-E224-4AE9-993E-4A71C199BD96Q21123568-DADAE20C-ABA0-4D8E-A948-EE57044EAA5AQ21130042-99BB7A22-C146-425A-AB21-5C460641E4DBQ21131341-53E2A33C-4E3B-486C-8C61-DE7C746A1C85Q21134245-3CD88321-8F23-4952-8837-525E62F0FD1EQ21134249-476547D7-0C60-499C-BD2A-5326847644ABQ21155117-AA016D0A-0E27-4DB2-AB07-F8705CAEEF59Q21175110-498A93CA-5B40-437F-A269-374CB2890AE2Q21422707-BA82E77B-F3E0-4492-8FE8-465CD04B4406Q21422709-51E30FAA-FC1F-4A61-865E-DE970063C5C2Q21422710-2E4E819B-DA1F-4BED-BAD1-F204FCEF5B21Q21422711-0B3B41A3-01D3-465C-B438-DBF188E13FF0Q21425019-7D8B707B-68DE-4787-84F3-13A87E1E978DQ21495733-05E6D157-F2A8-4E07-8858-20D0564BDFD0Q21497415-268B2D9B-46E1-45DA-A430-E90C2D1B3E30Q21498060-059B9CDF-3F45-46C5-A991-4433DC552EBCQ21980287-DF75A0CA-A922-454F-A62B-A1B42B15D7C2Q21981580-F1B843B4-489F-4A13-A0E1-CB370E05E1A2Q21989576-E5536232-2988-4EEC-8A97-5CA0530947F2Q21989961-7BD703C2-E18F-420A-AA2A-BFADD1062D97Q22680234-E53B4A70-466D-441C-ABCE-6AB61C1F1BC8
P682
description
The chemical reactions and pat ...... en if not used in medical or v
@en
biologisch proces
@nl
name
drug metabolic process
@en
legemiddelmetabolisme
@nn
metabola procezo pri medikamento
@eo
type
label
drug metabolic process
@en
legemiddelmetabolisme
@nn
metabola procezo pri medikamento
@eo
altLabel
GO:0017144
@en
drug metabolism
@en
prefLabel
drug metabolic process
@en
legemiddelmetabolisme
@nn
metabola procezo pri medikamento
@eo
P279
P2888
P5082
legemiddelmetabolisme
P686
GO:0017144